REFERENCES
- White NJ, Warell DA, Looareesuwan S, Chanthavanich P, Phillips RE, Pongpaew P. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet 1985; i: 776–778.
- Warell DA, Veal N, Chanthavanich P et al. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet 1988; 534–537.
- Clark IA, Al Yaman FM, Jacobson LS. The biological basis of malarial disease. Int J Parasitol 1997; 27: 1237–1249.
- Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988; 96: 579–589.
- Sanni L, Rae C, Maitland A, Stocker R, Hunt NH. Is ischaemia involved in the pathogenesis of murine cerebral malaria? Manuscript in preparation.
- Stacpoole PW. The pharmacology of dichloroacetate. Metab Clin Exp 1989; 38: 1124–1144.
- Griffin JL, Rae C, Dixon RM, Radda GK, Matthews PM. Excitatory amino acid synthesis in hypoxic brain slices: does alanine act as a substrate for glutamate production in hypoxia?J Neurochem 1998; 71: 2477-2486.
- Chang LH, Shimizu H, Abiko H et al. Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats. J Cereb Blood Flow Metab 1992; 12: 1030–1038.
- Krishna S, Supanaranond W, Pukrittayakamee S et al. Dichloro-acetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metab Clin Exp 1994; 43: 974–981.